• Mumbai, India
  • Open 24 x 7

Dr. Ramakant Deshpande

Dr. Ramakant Deshpande

MBBS, MS - General Surgery, FICS, FAIS, DHA, Surgical Oncologist
  • Skills :
    Treatment of Lung Cancer, Thoracic Cancer, Gastrointestinal Cancer, Breast Cancer
Meet Dr. Ramakant Deshpande

MEET DR. RAMAKANT DESHPANDE

Dr. Ramakanta Deshpande is a pioneering onco-surgeon with over four decades of experience in thoracic and breast oncology. He is widely recognized for advancing minimally invasive thoracoscopic cancer surgery in India and has performed thousands of complex cancer surgeries with exceptional clinical outcomes.

With his deep expertise across thoracic and breast cancers, he is known for structured clinical planning, evidence-based decision-making, and compassionate patient communication. His work has significantly shaped modern cancer care protocols in India, earning him the prestigious Padma Shri.

Conditions Treated by Dr. Ramakant Deshpande

CONDITIONS TREATED

Thoracic Cancers:
• Lung Cancer (NSCLC & SCLC)
• Esophageal Cancer
• Mediastinal Tumors
• Thymoma & Thymic Malignancies
• Chest Wall Tumors
• Pleural Tumors

Breast Oncology:
Breast Cancer – All Stages & Subtypes

Key Focus Areas of Dr. Ramakant Deshpande

KEY FOCUS AREAS

• Minimally Invasive Thoracoscopic (VATS) Surgery
• Robotic Thoracic Oncology
• Breast-Conserving Surgery
• Modified Radical Mastectomy
• Sentinel Lymph Node Biopsy
• Oncoplastic Breast Surgery
• Organ-Preserving Surgical Oncology
• High-Risk & Complex Cancer Surgeries
• PET-CT-Based Staging & Multidisciplinary Planning
• Enhanced Recovery After Surgery (ERAS)

Why Patients Choose Dr. Ramakant Deshpande?

WHY PATIENTS CHOOSE DR. RAMAKANT DESHPANDE?

• Padma Shri–honoured senior cancer surgeon with 40+ years of experience
• Pioneer of minimally invasive thoracic cancer surgery in India
• Expertise in complex and high-risk cancer surgeries
• Strong focus on organ preservation and minimally invasive methods
• Evidence-based, multidisciplinary decision-making
• Thousands of successfully treated patients nationally & internationally

Leadership and Academic Contributions of Dr. Ramakant Deshpande

LEADERSHIP & ACADEMIC CONTRIBUTIONS

• Led thoracic oncology at a leading national cancer institute
• Speaker at national & international oncology conferences
• Mentor to upcoming surgical oncologists
• Credited with over 50 publications, both books and articles published in national and international journals

Trainings and Certifications of Dr. Ramakant Deshpande

TRAININGS & CERTIFICATIONS

• MBBS
• MS – Tata Memorial Hospital
• Fellow – International College of Surgeons (FICS)
• Fellow – Academy of Medical Sciences (FAMS)
• Higher training stint at the Memorial Sloan Kettering Cancer Center, New York
• Advanced training in Thoracic Oncology, VATS, Breast Oncoplasty, Multidisciplinary Cancer Care

Advanced Procedures and Treatments Offered by Dr. Ramakant Deshpande

ADVANCED PROCEDURES & TREATMENTS

Thoracic Oncology:
• Thoracoscopic Lobectomy / Pneumonectomy
• Robotic Lung Cancer Surgery
• Esophagectomy
• Mediastinal Mass Removal
• Thymic Tumor Surgery
• Chest Wall Reconstruction

Breast Oncology:
• Breast-Conserving Surgery (Lumpectomy)
• Modified Radical Mastectomy
• Sentinel Lymph Node Biopsy
• Oncoplastic Breast Surgery
• Immediate Breast Reconstruction

Frequently Asked Questions (FAQs):

Q1. Is lung cancer always operable?

A. No. Operability depends on PET-CT staging, lung and heart function, and overall health status.

Q2. Can breast cancer be treated without removing the entire breast?

A. Yes. Many early-stage cases can be treated with breast-conserving surgery combined with radiation.

Q3. What are the benefits of minimally invasive thoracic surgery?

A. Less pain, faster recovery, shorter hospital stay, and fewer complications.

Q4. Is surgery safe for elderly cancer patients?

A. Yes, provided cardiac and pulmonary assessments are favourable. Many elderly patients undergo successful surgeries.

Q5. Is chemotherapy always needed after cancer surgery?

A. Not always. It depends on the pathology report, tumour biology, and stage.

Q6. How can long-distance or international patients do follow-ups?

A. Through online consultations, digital report reviews, and structured follow-up schedules coordinated by the care team.

Hi, How Can We Help You?